Goldman Sachs’s Foghorn Therapeutics FHTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $164K | Sell |
|
|||||
|
2025
Q1 | $206K | Sell |
|
|||||
|
2024
Q4 | $352K | Buy |
|
|||||
|
2024
Q3 | $424K | Buy |
|
|||||
|
2024
Q2 | $87.4K | Buy |
|
|||||
|
2024
Q1 | $76.6K | Sell |
|
|||||
|
2023
Q4 | $91.9K | Sell |
|
|||||
|
2023
Q3 | $79.8K | Buy |
|
|||||
|
2023
Q2 | $107K | Sell |
|
|||||
|
2023
Q1 | $193K | Sell |
|
|||||
|
2022
Q4 | $216K | Buy |
|
|||||
|
2022
Q3 | $145K | Buy |
|
|||||
|
2022
Q2 | $223K | Buy |
|
|||||
|
2022
Q1 | $200K | Sell |
|
|||||
|
2021
Q4 | $833K | Buy |
|
|||||
|
2021
Q3 | $178K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $220K | Buy |
|